Quantum waiver

RegenQuantum Cell Factors Waiver

Informed consent, assumption of risk, release & indemnification

This Informed Consent, Assumption of Risk, Release, and Indemnification Agreement (“Agreement”) is entered into by and between the undersigned individual (“Client”) and RegenTherapy™, including all affiliated entities, partners, contractors, medical directors, clinicians, distributors, and associated organizations.

1. Nature of the Product and Services

Client acknowledges that they are electing to receive Quantum cell factors–based products, including proprietary formulations marketed under the RegenQuantum platform (“Products”).

Client understands and agrees that:

• Quantum cell factors are not pharmaceutical drugs

• Quantum cell factors are not FDA-approved to diagnose, treat, cure, or prevent any disease

• Administration may be considered off-label, investigational, or wellness-based

• Individual responses vary and no results are guaranteed

2. Routes of Administration

Client understands and consents that RegenQuantum cell factors may be administered via one or more of the following routes, as determined appropriate by the Provider:

• Intravenous (IV)

• Subcutaneous (SQ)

• Intranasal (IN)

• Intramuscular (IM)

• Or other non-standard routes

Client acknowledges that each route of administration carries inherent risks, which may differ by individual.

3. Medical Condition & Disclosure Attestation

Client hereby represents, warrants, and attests that all of the following statements are true and accurate:

• Client is in generally good medical condition

• Client has fully and accurately disclosed all known medical conditions, diagnoses, surgeries, allergies, and relevant health history

• Client has disclosed all medications, supplements, hormones, peptides, and therapies currently being used

• Client denies current or recent illicit drug use

• Client denies alcohol abuse or intoxication at the time of administration

• Client is not pregnant, not attempting pregnancy, and not breastfeeding

• Client has no active cancer and is not undergoing chemotherapy or radiation therapy

Client understands that failure to disclose complete and accurate medical information materially increases risk and releases the Released Parties from liability related to undisclosed information.

4. Risks, Benefits & Unknowns

Client acknowledges understanding that potential risks may include, but are not limited to:

• Injection-site reactions (pain, bruising, swelling, irritation)

• IV-related complications (infection, infiltration, vein irritation)

• Headache, flushing, dizziness, fatigue, or nausea

• Unforeseen or unknown reactions

Client understands that potential benefits are not guaranteed, responses vary by individual, and long-term effects may not be fully known.

5. Voluntary Participation

Client affirms that:

• Participation is entirely voluntary

• No coercion, pressure, or guarantee of outcome has been made

• Client has had the opportunity to ask questions and receive satisfactory answers

• Client is proceeding of their own free will

6. Assumption of Risk

Client knowingly and voluntarily assumes all risks, known and unknown, associated with the use and administration of RegenQuantum cell factors, regardless of route of administration.

7. Release, Hold Harmless & Indemnification

To the fullest extent permitted by law, Client hereby releases, waives, discharges, and holds harmless the Released Parties from any and all claims, liabilities, damages, losses, costs, or expenses (including reasonable attorneys’ fees) arising out of or related to:

• The use or administration of RegenQuantum Products

• Adverse reactions or outcomes

• Off-label or investigational use

• Incomplete or inaccurate medical disclosures

Client further agrees to indemnify and defend the Released Parties against any claims brought by third parties arising from Client’s participation.

8. No Medical Guarantee

Client understands that RegenQuantum Products:

• Are not a substitute for medical care

• Do not replace diagnosis or treatment of disease

• Carry no guarantee of benefit or outcome

9. Compliance & Follow-Up

Client agrees to follow all pre- and post-administration instructions and to promptly report any adverse symptoms. Client understands they may discontinue participation at any time.

10. Governing Law & Severability

This Agreement shall be governed by the laws of the state in which services are rendered. If any provision is deemed unenforceable, the remaining provisions shall remain in full force and effect.

11. Acknowledgment & Consent

By accepting these terms, Client confirms that they have read, understood, and voluntarily agreed to all terms of this Agreement.